Misplaced Pages

Paul Ehrlich Institute

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
#831168

6-507: The Paul Ehrlich Institute (German: Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel , PEI) is a German federal agency , medical regulatory body and research institution for vaccines and biomedicines. It was founded in 1896 and is subordinate to the Federal Ministry of Health . The institute is a WHO Collaborating Centre for quality assurance of blood products and in vitro diagnostic devices. It

12-681: Is located in Langen, Hesse , near Frankfurt , and was located in Frankfurt for most of the 20th century. It is named for its founding director, the immunologist and Nobel Prize laureate Paul Ehrlich . The Paul Ehrlich Institute was founded on 1 June 1896 in Steglitz , Berlin as the Institute for Serum Research and Serum Testing ( Institut für Serumforschung und Serumprüfung ), with immunologist Paul Ehrlich , one of Germany's most prominent medical researchers at

18-727: The Paul Ehrlich Institute include the marketing authorisation of particular groups of medicinal products and the approval of clinical trials . The medicinal products in the responsibility of the PEI are: vaccines for humans and animals, medicinal products containing antibodies , allergens for therapy and products for diagnostic tests, blood and blood products and tissue and medicinal products for gene therapy , somatic cell therapy and xenogenic cell therapy. Federal agency (Germany) Federal agencies in Germany are established to assist

24-621: The country's executive branch on the federal level according to Article 86 of the Basic Law for the Federal Republic of Germany ( Grundgesetz ). They are hierarchically organized on four levels: According to Article 83 of the Grundgesetz , federal laws are generally enforced by the executive branch of the German states , except for laws referring to those explicit items that are enumerated in

30-595: The time, as its first director. The institute was founded specifically to provide a platform for Ehrlich's research. In 1899, it moved to Frankfurt and was renamed the Royal Institute for Experimental Therapy ( Königliches Institut für experimentelle Therapie ). After Germany had become a republic in 1919, it was renamed the National Institute for Experimental Therapy ( Staatliches Institut für Experimentelle Therapie ). Ehrlich received numerous honours in Germany and

36-424: Was awarded the 1908 Nobel Prize in medicine . In 1947, the institute was renamed the Paul Ehrlich Institute in honour of its founding director. In 1987, the institute moved from Paul-Ehrlich-Straße in Frankfurt to Langen, Hesse , a suburb south of Frankfurt. In 2009, the addition Bundesamt für Sera und Impfstoffe was renamed Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel . The regulatory tasks of

#831168